A Meneses-Garcia

Summary

Publications

  1. pmc Prognostic factors and recurrence in breast cancer: experience at the national cancer institute of Mexico
    A Stankov
    Breast Cancer Department, National Cancer Institute of Mexico, 14080 Tlalpan, DF, Mexico
    ISRN Oncol 2012:825258. 2012
  2. ncbi request reprint [Overweight, obesity, diabetes, and hypertension in endometrial cancer]
    Tania L N Sanz-Chávez
    Departamento de Nutricion, Instituto Nacional de Cancerologia, Distrito Federal, Mexico, Mexico
    Rev Med Inst Mex Seguro Soc 51:326-9. 2013
  3. ncbi request reprint [Main malignant neoplasms in Mexico and their geographic distribution, 1993-2002]
    Abelardo Meneses-García
    Instituto Nacional de Cancerologia
    Rev Invest Clin 64:322-9. 2012
  4. ncbi request reprint Costs of breast cancer treatment prior to the introduction of immune-based therapy in Mexico
    Abelardo Meneses-García
    Instituto Nacional de Cancerologia, Secretaria de Salud, Distrito Federal, Mexico, Mexico
    Rev Med Inst Mex Seguro Soc 50:19-24. 2012
  5. pmc Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas
    Abelardo Meneses-García
    Pathology Department, Instituto Nacional de Cancerologia, Mexico
    World J Surg Oncol 6:114. 2008
  6. ncbi request reprint Histopathological diagnosis of biopsy samples from early esophageal carcinoma
    A Meneses-Garcia
    Subdirection of Pathology, Instituto Nacional de Cancerologia, Tlalpan, Mexico DF
    J Exp Clin Cancer Res 21:621-6. 2002
  7. ncbi request reprint [Metalloproteinase (MMP-1, 2 and 11), tissue inhibitor of metalloproteinase-1 (TIMP-1), and p53 expression in nasal-type angiocentric T/NK-cell lymphoma: an immunohistochemical study]
    Abelardo Meneses-García
    Instituto Nacional de Cancerologia, DF, Mexico
    Gac Med Mex 141:291-6. 2005

Collaborators

  • Diana Vilar-Compte
  • T Kawano
  • Tania L N Sanz-Chávez
  • A Stankov
  • Luigina de Nicola-Delfín
  • K Stankova-Ninova
  • M T Ramirez
  • J E Bargallo-Rocha
  • A Ñamendys Silva Silvio

Detail Information

Publications7

  1. pmc Prognostic factors and recurrence in breast cancer: experience at the national cancer institute of Mexico
    A Stankov
    Breast Cancer Department, National Cancer Institute of Mexico, 14080 Tlalpan, DF, Mexico
    ISRN Oncol 2012:825258. 2012
    ..47; CI (confidence interval), 1.52-7.91) and the pathological complete response of the patient to neoadjuvant chemotherapy (yes versus no; P = 0.061; HR, 0.38; CI, 0.14-1.04) were important prognostic factors for recurrence...
  2. ncbi request reprint [Overweight, obesity, diabetes, and hypertension in endometrial cancer]
    Tania L N Sanz-Chávez
    Departamento de Nutricion, Instituto Nacional de Cancerologia, Distrito Federal, Mexico, Mexico
    Rev Med Inst Mex Seguro Soc 51:326-9. 2013
    ..The aim of the study was to determine the prevalence of overweight, obesity, diabetes and hypertension in patients with endometrial cancer...
  3. ncbi request reprint [Main malignant neoplasms in Mexico and their geographic distribution, 1993-2002]
    Abelardo Meneses-García
    Instituto Nacional de Cancerologia
    Rev Invest Clin 64:322-9. 2012
    ..INTRODUCCION: Cancer is one of the main causes of death worldwide. In Mexico it represents the third cause of death. OBJECTIVE. To know the frequency and distribution of the malignancies diagnosed in Mexico during 10 years...
  4. ncbi request reprint Costs of breast cancer treatment prior to the introduction of immune-based therapy in Mexico
    Abelardo Meneses-García
    Instituto Nacional de Cancerologia, Secretaria de Salud, Distrito Federal, Mexico, Mexico
    Rev Med Inst Mex Seguro Soc 50:19-24. 2012
    ..the aim was to perform a cost analysis on direct data of integral medical care provided to BC patients prior to introduction of immunotherapy...
  5. pmc Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas
    Abelardo Meneses-García
    Pathology Department, Instituto Nacional de Cancerologia, Mexico
    World J Surg Oncol 6:114. 2008
    ..Prognosis is poor in the short term. The objective is to explore the expression of different MMPs in the cells and stroma which are around of the blood vessels damaged and their correlation with clinico-pathological parameters...
  6. ncbi request reprint Histopathological diagnosis of biopsy samples from early esophageal carcinoma
    A Meneses-Garcia
    Subdirection of Pathology, Instituto Nacional de Cancerologia, Tlalpan, Mexico DF
    J Exp Clin Cancer Res 21:621-6. 2002
    ....
  7. ncbi request reprint [Metalloproteinase (MMP-1, 2 and 11), tissue inhibitor of metalloproteinase-1 (TIMP-1), and p53 expression in nasal-type angiocentric T/NK-cell lymphoma: an immunohistochemical study]
    Abelardo Meneses-García
    Instituto Nacional de Cancerologia, DF, Mexico
    Gac Med Mex 141:291-6. 2005
    ..We studied immunophenotype of neoplastic cells, nuclear p53 expression, and enzymes as matrix metalloplroteinases participating in invasion, tissular destruction and metastases...